Curaderm Bec5 is formulated specifically for certain types of non-melanoma skin cancer, including basal cell carcinoma, squamous cell carcinoma in situ, and active keratosis. It’s important to understand what Curaderm can and cannot treat to avoid misuse, potential disappointment, and adverse reactions.
Conditions Curaderm is designed for:
- Superficial basal cell carcinoma (sBCC)
- Squamous cell carcinoma in situ
- Actinic keratosis (precancerous skin growth)
These are all surface-level lesions with abnormal cells that express receptors targeted by Curaderm’s active compounds – solasodine glycosides.
Conditions Curaderm is NOT approved to treat:
- Melanoma. This aggressive skin cancer forms in pigment-producing cells and requires surgical or advanced medical intervention. Curaderm is not suitable and should not be used on melanomas.
- Ordinary moles. Moles are generally benign, and treatment should only be done by a medical professional if necessary. Using Curaderm on moles may be ineffective or irritating.
- Warts. Caused by the HPV virus, warts require antiviral or immune-modulating treatments, not Curaderm whic is a cancer-targeting cream.
If you’re unsure what type of lesion you have, see a dermatologist for a proper diagnosis before starting any treatment. Using Curaderm on the wrong type of skin issue can delay care or cause skin irritation.
Correct diagnosis is critical and should not be avoided, especially when dealing with skin abnormalities. When used as directed and on suitable conditions, Curaderm has shown promising results. But it’s not a catch-all skin remedy and should only be used on the conditions it was designed to treat.